Company: CERO
Filing Date: 2025-08-22
Form Type: 10-Q
Source: 0001213900-25-079898
Chunk: 486

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-22
Form: 10-Q
Item: Part II, Item 1A
Chunk 486
---
 Securities and Exchange
    Commission on June 11, 2025).

    4.1
     
    Form
    of Common Warrant (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings,
    Inc. with the Securities and Exchange Commission on February 6, 2025).

    4.2
     
    Form
    of Pre-Funded Warrant (incorporated by reference to Exhibit 4.8 to the Registration Statement on Form S-1/A filed by CERo Therapeutics
    Holdings, Inc. with the Securities and Exchange Commission on January 21, 2025).

    4.3
     
    Description
    of Securities (incorporated by reference to Exhibit 4.4 to the Current Report on Form S-1 filed by CERo Therapeutics Holdings, Inc.
    with the Securities and Exchange Commission on July 21, 2025).

    10.1+†
     
    Securities
    Purchase Agreement, dated as of April 21, 2025, by and between CERo Therapeutics Holdings, Inc. and the investors named therein (incorporated
    by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings, Inc. with the Securities and
    Exchange Commission on April 22, 2025).

    10.2+
     
    Form
    of Registration Rights Agreement by and between CERo Therapeutics Holdings, Inc. and the investors signatory thereto (incorporated
    by reference to Exhibit 10.2 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings, Inc. with the Securities and
    Exchange Commission on April 22, 2025).

    10.3
     
    Form
    of Consent Agreement (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings,
    Inc. with the Securities and Exchange Commission on April 22, 2025).

    10.4†
     
    Form
    of Amendment to the Securities Purchase Agreement (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed
    by CERo Therapeutics Holdings, Inc. with the Securities and